Skip to content
10-Q

Quarterly Report

INTERMOLECULAR INC

0001564590-19-019157

← back to feed
Filed
May 14, 2019 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2019 · May 10, 2019 49.76M sh
Capex Q1 2019 · Mar 31, 2019 $134K
Capex Q1 2019 · Mar 31, 2018 $194K
Operating Cash Flow Q1 2019 · Mar 31, 2019 −$2.92M
Operating Cash Flow Q1 2019 · Mar 31, 2018 $1.69M
Short Term Investments Q1 2019 · Mar 31, 2019 $23.61M
Short Term Investments Q1 2019 · Dec 31, 2018 $22.1M
Cash And Equivalents Q1 2019 · Mar 31, 2019 $3.82M
Cash And Equivalents Q1 2019 · Dec 31, 2018 $8.35M
Stockholders Equity Q1 2019 · Mar 31, 2019 $32.63M
Stockholders Equity Q1 2019 · Dec 31, 2018 $34.38M
Stockholders Equity Q1 2019 · Mar 31, 2018 $36.19M
Stockholders Equity Q1 2019 · Dec 31, 2017 $36.07M
Current Liabilities Q1 2019 · Mar 31, 2019 $5.28M
Current Liabilities Q1 2019 · Jan 1, 2019 $7.87M
Current Liabilities Q1 2019 · Dec 31, 2018 $6.34M
Total Liabilities Q1 2019 · Mar 31, 2019 $17.58M
Total Liabilities Q1 2019 · Jan 1, 2019 $20.64M
Total Liabilities Q1 2019 · Dec 31, 2018 $9.01M
Current Assets Q1 2019 · Mar 31, 2019 $30.83M
Current Assets Q1 2019 · Dec 31, 2018 $34.73M
Total Assets Q1 2019 · Mar 31, 2019 $50.21M
Total Assets Q1 2019 · Jan 1, 2019 $55.02M
Total Assets Q1 2019 · Dec 31, 2018 $43.39M
Sga Expense Q1 2019 · Mar 31, 2019 $2.34M
Sga Expense Q1 2019 · Mar 31, 2018 $2.29M
Rd Expense Q1 2019 · Mar 31, 2019 $4.15M
Rd Expense Q1 2019 · Mar 31, 2018 $4.03M
Net Income Q1 2019 · Mar 31, 2019 −$2.26M
Net Income Q1 2019 · Mar 31, 2018 −$623K
Operating Income Q1 2019 · Mar 31, 2019 −$2.54M
Operating Income Q1 2019 · Mar 31, 2018 −$815K
Gross Profit Q1 2019 · Mar 31, 2019 $4.83M
Gross Profit Q1 2019 · Mar 31, 2018 $6.3M
Cost Of Revenue Q1 2019 · Mar 31, 2019 $1.82M
Cost Of Revenue Q1 2019 · Mar 31, 2018 $3.38M
Revenue Q1 2019 · Mar 31, 2019 $6.65M
Revenue Q1 2019 · Mar 31, 2018 $9.68M